HPGDS and Duchenne muscular dystrophy: To date, oral HPGDS inhibitors, such as TAS-205, have been tested in DMD boys [39], whilst HQL-79 [54] and PK007 (our novel compound) have been tested in the mdx mouse model of DMD [84].